Home/Filings/4/0001096481-09-000009
4//SEC Filing

ANGIOTECH PHARMACEUTICALS INC 4

Accession 0001096481-09-000009

CIK 0001096481operating

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 7:17 PM ET

Size

6.1 KB

Accession

0001096481-09-000009

Insider Transaction Report

Form 4
Period: 2009-03-10
Diaz Victor Manuel
Sr VP, Global Manufacturing
Transactions
  • Award

    Stock Option w/Tandem SAR

    2009-03-10+150,000330,000 total
    Exercise: $0.27From: 2009-04-01Exp: 2014-03-09Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]The options will start to vest effective 04/01/2009 in equal installments on a monthly basis until 03/01/2013.
  • [F2]Represents the number of the Company's common shares into which the stock options are convertible. In the event that the Reporting Person elects to exercise the tandem SAR, the stock option will be cancelled and the Reporting Person will be entitled to receive a number of common shares with an aggregate value equal to the product of (a) the excess of the market price of a common share on the date of exercise over the price of the tandem SAR, multiplied by (b) the number of tandem SARs exercised.

Issuer

ANGIOTECH PHARMACEUTICALS INC

CIK 0001096481

Entity typeoperating

Related Parties

1
  • filerCIK 0001096481

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 7:17 PM ET
Size
6.1 KB